QR Code

OCEANIC-AF and the inferior efficacy of asundexian compared to apixaban in patients at high risk with atrial fibrillation: Have we come to the end of the road for factor XIa inhibitors?

I tiakina i:
Ngā taipitopito rārangi puna kōrero
Ngā kaituhi matua: Keith C. Ferdinand, Asaad Nakhle
Hōputu: Artigo
Reo:Inglês
I whakaputaina: Elsevier 2024-10-01
Rangatū:American Heart Journal Plus
Ngā marau:
Urunga tuihono:http://www.sciencedirect.com/science/article/pii/S2666602224001071
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!